About the newsletter
- Our monthly issues highlight CDC’s global work and impact.
- Receive up-to-date information on global public health issues, emerging diseases and outbreaks, and policy developments.
- Explore our success stories, health campaigns, news, videos, publications, and more.
Subscribe to our newsletter
Sign up for our email newsletter below.
Our latest issue
2026 Global Health Security Conference
CDC’s global work is America’s first line of defense. As the ongoing Ebola outbreak demonstrates, protecting Americans requires stopping threats wherever they emerge. For more than 80 years, CDC has been at the forefront of detecting, responding to, and containing global health threats—working with countries around the world to stop outbreaks before they become global crises or reach the United States.
At the 2026 Global Health Security Conference (GHS 2026) held June 9–12 in Kuala Lumpur, Malaysia, CDC joined global leaders, scientists, and policymakers to advance exactly the global mission—sharing operational lessons, scientific findings, and strategies to strengthen outbreak detection, preparedness, and rapid response capabilities worldwide. CDC experts presented more than 20 oral presentations and posters, showcasing scientific findings from real-world outbreak responses across more than 40 countries.
Read more in this issue to learn how findings from GHS 2026 are improving real-world outbreak responses worldwide.
Strengthening Global Health Security Through Partnership
At GHS 2026, CDC’s Global Health Center Director, Dr. Paige Armstrong joined discussions with key global health leaders and partners on collaboration in health security, pandemic preparedness, and the trilateral partnership among the U.S., the Republic of Korea, and Ghana. CDC colleagues presented across multiple technical sessions and held 20 bilateral meetings with key partners. These engagements demonstrated CDC’s technical leadership and reaffirmed U.S. commitment to global health security.
CDC Leadership on Countering Biothreats
CDC’s Division of Global Health Protection Director Dr. Benjamin Park helped lead the “Countering Biothreats” plenary discussion, highlighting CDC’s real-world experience addressing deliberate biological threats and the importance of strong systems to rapidly detect and contain outbreaks before they spread.
Every Outbreak Prevented is Cost Avoided
A new CDC analysis found that investments in surveillance, laboratories, and workforce helped contain 10 Ebola outbreaks in Sub-Saharan Africa between 2016 and 2023—avoiding an estimated $11.68 billion in economic losses and generating more than a four-to-one return on investment.
CDC’s global health security work is economically strategic. Stopping outbreaks abroad protects trade, travel, and supply chains—and delivers strong returns by avoiding costly domestic responses, healthcare expenditures, and economic disruption. Every dollar spent preventing outbreaks protects American workers, U.S. businesses, and supply chains from devastating losses. Every outbreak prevented is a crisis—and a cost—avoided.
Strengthening Sierra Leone’s Monkeypox Response
In a study presented at GHS 2026, CDC partnered with Sierra Leone to strengthen the country’s monkeypox response by improving coordination, deploying 167 personnel across 13 rapid response teams, and reducing daily cases within 12 weeks. Strengthening real-time outbreak response systems helps reduce global health risks and protects Americans at home and abroad.
Advanced Laboratory Testing in Vietnam
Genomic surveillance is changing the game in outbreak detection. One CDC study of genomic surveillance from Vietnam demonstrated how advanced laboratory testing helped detect circulating infectious pathogens to identify how diseases were spreading, allowing global health experts to focus their response where it mattered most.
Strengthening Ghana’s Response Efforts
When monkeypox resurged in Ghana in 2025, the Ghana Health Service and CDC worked together to lead a swift, coordinated response. As highlighted at GHS 2026, together, they strengthened surveillance, deployed laboratory diagnostics, and launched targeted vaccination efforts—delivering 33,000 vaccines to high-risk populations across affected regions—driving a decline in cases in just 4 weeks
